Rising controversy over position of FDA and Medicare in selling anti-amyloid medication given restricted profit, excessive value, extreme side-effects
The War Over Whether Medicare Should Pay For The New Anti-Alzheimer’s Drugs (Forbes): The powerful Alzheimer’s Disease lobby is struggleing...
